Atlas Trials

Hereditary Tyrosinemia, Type I

9 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Hereditary Tyrosinemia, Type I

RecordFirmDate
Bio Equivalency 20 Mgm Orfadin and 20 Mgm of Nitisonine (NCT04113772)Sutphin Drugs2019-11-01
Hereditary Hepatorenal Tyrosinemia Natural History in Egypt and the Arab World (Multicenter Clinical Study) (NCT03446586)Yassin Abdelghaffar Charity Center for Liver Disease and Research2019-04-05
Bioequivalence Study of Two Oral Nitisinone Formulations to Treat Hereditary Tyrosinemia (HT-1) (NCT02750345)Cycle Pharmaceuticals Ltd.2016-03-01
Bioavailability Food-Effect Study of an Oral Nitisinone Formulation to Treat Hereditary Tyrosinemia (HT-1) (NCT02750332)Cycle Pharmaceuticals Ltd.2015-11-01
Bioequivalence Study of Two Nitisinone Formulations Compared to Orfadin (NCT02750709)Cycle Pharmaceuticals Ltd.2015-10-01
Efficacy and Safety of Once Daily Dosing Compared to Twice Daily Dosing of Nitisinone in HT-1 (NCT02323529)Swedish Orphan Biovitrum2014-12-01
Long Term Safety Study of Orfadin Treatment in HT-1 Patients in Standard Clinical Care (NCT02320084)Swedish Orphan Biovitrum2013-09-01
Taste and Palatability of Orfadin Suspension (NCT01734889)Swedish Orphan Biovitrum2012-10-01

Track Hereditary Tyrosinemia, Type I automatically

Every clearance here is in the API, with alerts when new ones post.